adplus-dvertising
Connect with us

Health

B.C.’s ‘extremely medically vulnerable’ can begin booking COVID-19 shots March 29 – Cranbrook Townsman

Published

 on


People deemed clinically extremely vulnerable will be able to register for a COVID-19 vaccine appointment starting on March 29.

In a Tuesday (March 23) news release, the province said that about 200,000 people with conditions that compromise their immunity will get a letter from the health ministry starting this week and might also be contacted by their treatment clinic or local health authority. That letter will let them begin to book appointments at noon on March 29.

The province said the conditions were determined by looking at people who have ended up in hospital, ICU or died due to COVID-19. Data from B.C. was used to determine which risk factors were most linked to serious illness or death from COVID and experts in cancer care, kidney disease, transplant, rheumatology, diabetes and developmental concerns, came together to review all the data and give clinical advice.

Ethics experts were consulted to make sure the list was fair to the rest of B.C.’s population.

READ MORE: Health officials give timetable for vaccinating all B.C. adults by July

B.C.’s aged based vaccination schedule was also moved up by one day. The timetable for seniors between the ages of 74 and 76 is:

  • Wednesday, March 24 at noon for people born in 1945 (age 76)
  • Thursday, March 25 at noon for people born in 1946 (aged 75)
  • Friday, March 26 at noon for people born in 1947 (aged 74)

The list of eligible clinically extremely vulnerable conditions includes:

People who have undergone a transplant:

  • People who have received a solid organ transplant at any time in their life

People with specific cancers:

  • People who have had systemic therapy for cancer now or have had it in the past 12 months, this includes chemotherapy, molecular therapy, immunotherapy, monoclonal antibodies and hormonal therapy for cancer.
  • People who are receiving radiation therapy for cancer now or in the past six months
  • People having or who have had targeted cancer treatments that can affect the immune system, such as CAR-T cell treatments in the past six months
  • People who have blood or bone marrow cancer (such as leukemia, lymphoma, myeloma and myelodysplastic disorders)
  • People who have had a bone marrow or stem cell transplant in the past six months, or are still taking immunosuppressant medicine related to the transplant

People with severe respiratory conditions: cystic fibrosis, severe chronic obstructive pulmonary disease (COPD), severe asthma:

  • cystic fibrosis: anyone with this condition (aged 16 and older)
  • people who have been hospitalized because of COPD at least one time since April 2018
  • People who have been hospitalized because of asthma at least one time since April 2018

People with rare blood diseases

  • including homozygous sickle cell disease, highest-risk thalassemia, meaning thalassemia and two of the following: transfusion dependent, receiving iron chelation therapy, pre-transfusion hemoglobin level of less than 70 in the last two to three years
  • people who have iron overload
  • people who have had their spleen taken out as treatment for thalassemia or have other significant health conditions
  • people who are over the age of 50
  • adults with atypical hemolytic uremia syndrome (aHUS) or paroxysmal nocturnal hemoglobinuria (PNH)

Other rare diseases:

  • people who have a condition for which they see a metabolic (biochemical diseases) specialist and who are known to have a metabolically unstable inborn error of metabolism
  • people who have severe primary immunodeficiency, meaning these people have combined immune deficiencies affecting T-cells; familial hemophagocytic lymphohistiocytosis or have Type 1 interferon defects
  • received a splenectomy at any time in their life or have been told they have a spleen that does not function (functional asplenia)
  • People with diabetes who take insulin:
  • People currently using insulin for diabetes (pump or injection)

People with a significant developmental disability:

  • such as Down syndrome and other conditions, that is significant enough the person requires support for activities of daily living and therefore use or receive support from: Community Supports for Independent Living, Community Living British Columbia, Nursing Support Services program for youth aged 16 to 19

People on dialysis or with Stage 5 chronic kidney disease:

  • dialysis (hemo and peritoneal)
  • glomerulonephritis receiving steroids
  • chronic kidney disease stage 5 (eGFR 15 ml/min)

People who are pregnant and have heart disease:

  • people who are pregnant and have a serious heart condition, congenital or acquired, that requires the person to see a cardiac specialist during their pregnancy

People with neuromuscular/neurologic or muscle conditions who require respiratory support:

  • people with significant muscle weakness around their lungs, such that they need to use a ventilator or use bi-level positive airway pressure (BiPAP) continuously
  • These include many patients with spinal muscular atrophy, Pompe disease and Duchenne muscular dystrophy, as well as a range of other conditions that lead to muscle weakness around lungs and where the individual is using home ventilation or BiPAP on a continuous basis.

People whose immune system is affected by immunosuppression therapies they take, including people taking high dose steroids or other medicines known to suppress the immune system:

  • people taking the following biologics since Dec. 15, 2020: Abatacept, Adalimumab, Anakinra, Certolizumab, Etanercept, Golimumab, Infliximab, Ixekizumab, Ocrelizumab, Sarilumab, Secukinumab, Tocilizumab, or Ustekinumab
  • people taking the following oral drugs since Dec. 15, 2020: Azathioprine, Baricitinib, Cyclophosphamide, Cyclosporine, Leflunomide, Mycophenolate, Sirolimus, Tacrolimus, Tofacitinib, Upadacitinib, Methotrexate, Dexamethasone, Hydrocortisone, Prednisone, or Methylprednisolone
  • people taking the following oral or injectable steroid products since Dec. 15, 2020: Dexamethasone, Hydrocortisone, Methylprednisolone or Prednisone
  • people 16 to 18 years of age, taking Canikinumab or Vedolizumab since Dec.15, 2020
  • people taking Rituximab since Feb. 15, 2020

@katslepian

katya.slepian@bpdigital.ca

Like us on Facebook and follow us on Twitter.

Want to support local journalism during the pandemic? Make a donation here.

Coronavirus

Get local stories you won’t find anywhere else right to your inbox.
Sign up here

Let’s block ads! (Why?)

728x90x4

Source link

Continue Reading

Health

Canada to donate up to 200,000 vaccine doses to combat mpox outbreaks in Africa

Published

 on

 

The Canadian government says it will donate up to 200,000 vaccine doses to fight the mpox outbreak in Congo and other African countries.

It says the donated doses of Imvamune will come from Canada’s existing supply and will not affect the country’s preparedness for mpox cases in this country.

Minister of Health Mark Holland says the donation “will help to protect those in the most affected regions of Africa and will help prevent further spread of the virus.”

Dr. Madhukar Pai, Canada research chair in epidemiology and global health, says although the donation is welcome, it is a very small portion of the estimated 10 million vaccine doses needed to control the outbreak.

Vaccine donations from wealthier countries have only recently started arriving in Africa, almost a month after the World Health Organization declared the mpox outbreak a public health emergency of international concern.

A few days after the declaration in August, Global Affairs Canada announced a contribution of $1 million for mpox surveillance, diagnostic tools, research and community awareness in Africa.

On Thursday, the Africa Centres for Disease Control and Prevention said mpox is still on the rise and that testing rates are “insufficient” across the continent.

Jason Kindrachuk, Canada research chair in emerging viruses at the University of Manitoba, said donating vaccines, in addition to supporting surveillance and diagnostic tests, is “massively important.”

But Kindrachuk, who has worked on the ground in Congo during the epidemic, also said that the international response to the mpox outbreak is “better late than never (but) better never late.”

“It would have been fantastic for us globally to not be in this position by having provided doses a much, much longer time prior than when we are,” he said, noting that the outbreak of clade I mpox in Congo started in early 2023.

Clade II mpox, endemic in regions of West Africa, came to the world’s attention even earlier — in 2022 — as that strain of virus spread to other countries, including Canada.

Two doses are recommended for mpox vaccination, so the donation may only benefit 100,000 people, Pai said.

Pai questioned whether Canada is contributing enough, as the federal government hasn’t said what percentage of its mpox vaccine stockpile it is donating.

“Small donations are simply not going to help end this crisis. We need to show greater solidarity and support,” he said in an email.

“That is the biggest lesson from the COVID-19 pandemic — our collective safety is tied with that of other nations.”

This report by The Canadian Press was first published Sept. 13, 2024.

Canadian Press health coverage receives support through a partnership with the Canadian Medical Association. CP is solely responsible for this content.

The Canadian Press. All rights reserved.

Source link

Continue Reading

Health

How many Nova Scotians are on the doctor wait-list? Number hit 160,000 in June

Published

 on

 

HALIFAX – The Nova Scotia government says it could be months before it reveals how many people are on the wait-list for a family doctor.

The head of the province’s health authority told reporters Wednesday that the government won’t release updated data until the 160,000 people who were on the wait-list in June are contacted to verify whether they still need primary care.

Karen Oldfield said Nova Scotia Health is working on validating the primary care wait-list data before posting new numbers, and that work may take a matter of months. The most recent public wait-list figures are from June 1, when 160,234 people, or about 16 per cent of the population, were on it.

“It’s going to take time to make 160,000 calls,” Oldfield said. “We are not talking weeks, we are talking months.”

The interim CEO and president of Nova Scotia Health said people on the list are being asked where they live, whether they still need a family doctor, and to give an update on their health.

A spokesperson with the province’s Health Department says the government and its health authority are “working hard” to turn the wait-list registry into a useful tool, adding that the data will be shared once it is validated.

Nova Scotia’s NDP are calling on Premier Tim Houston to immediately release statistics on how many people are looking for a family doctor. On Tuesday, the NDP introduced a bill that would require the health minister to make the number public every month.

“It is unacceptable for the list to be more than three months out of date,” NDP Leader Claudia Chender said Tuesday.

Chender said releasing this data regularly is vital so Nova Scotians can track the government’s progress on its main 2021 campaign promise: fixing health care.

The number of people in need of a family doctor has more than doubled between the 2021 summer election campaign and June 2024. Since September 2021 about 300 doctors have been added to the provincial health system, the Health Department said.

“We’ll know if Tim Houston is keeping his 2021 election promise to fix health care when Nova Scotians are attached to primary care,” Chender said.

This report by The Canadian Press was first published Sept. 11, 2024.

The Canadian Press. All rights reserved.

Source link

Continue Reading

Health

Newfoundland and Labrador monitoring rise in whooping cough cases: medical officer

Published

 on

 

ST. JOHN’S, N.L. – Newfoundland and Labrador‘s chief medical officer is monitoring the rise of whooping cough infections across the province as cases of the highly contagious disease continue to grow across Canada.

Dr. Janice Fitzgerald says that so far this year, the province has recorded 230 confirmed cases of the vaccine-preventable respiratory tract infection, also known as pertussis.

Late last month, Quebec reported more than 11,000 cases during the same time period, while Ontario counted 470 cases, well above the five-year average of 98. In Quebec, the majority of patients are between the ages of 10 and 14.

Meanwhile, New Brunswick has declared a whooping cough outbreak across the province. A total of 141 cases were reported by last month, exceeding the five-year average of 34.

The disease can lead to severe complications among vulnerable populations including infants, who are at the highest risk of suffering from complications like pneumonia and seizures. Symptoms may start with a runny nose, mild fever and cough, then progress to severe coughing accompanied by a distinctive “whooping” sound during inhalation.

“The public, especially pregnant people and those in close contact with infants, are encouraged to be aware of symptoms related to pertussis and to ensure vaccinations are up to date,” Newfoundland and Labrador’s Health Department said in a statement.

Whooping cough can be treated with antibiotics, but vaccination is the most effective way to control the spread of the disease. As a result, the province has expanded immunization efforts this school year. While booster doses are already offered in Grade 9, the vaccine is now being offered to Grade 8 students as well.

Public health officials say whooping cough is a cyclical disease that increases every two to five or six years.

Meanwhile, New Brunswick’s acting chief medical officer of health expects the current case count to get worse before tapering off.

A rise in whooping cough cases has also been reported in the United States and elsewhere. The Pan American Health Organization issued an alert in July encouraging countries to ramp up their surveillance and vaccination coverage.

This report by The Canadian Press was first published Sept. 10, 2024.

The Canadian Press. All rights reserved.

Source link

Continue Reading

Trending